EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetically supported causality between gut microbiota, gut metabolites and low back pain: a two-sample Mendelian randomization study

Mengchan Su, Yidan Tang, Weishuang Kong, Shuangyi Zhang, Tao Zhu

Frontiers in Microbiology · 14.04.2023 · 14

DOI: 10.3389/fmicb.2023.1157451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 14.04.2023. Verfasst von Mengchan Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies have implicated a vital association between gut microbiota/gut microbial metabolites and low back pain (LBP), but their causal relationship is still unclear. Therefore, we aim to comprehensively investigate their causal relationship and identify the effect of gut microbiota/gut microbial metabolites on risk of LBP using a two-sample Mendelian randomization (MR) study.

Methods

Summary data from genome-wide association studies (GWAS) of gut microbiota (18,340 participants), gut microbial metabolites (2,076 participants) and LBP (FinnGen biobank) were separately obtained. The inverse variance-weighted (IVW) method was used as the main MR analysis. Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) and MR-Egger regression were conducted to evaluate the horizontal pleiotropy and to eliminate outlier single-nucleotide polymorphisms (SNPs). Cochran’s Q -test was applied for heterogeneity detection. Besides, leave-one-out analysis was conducted to determine whether the causal association signals were driven by any single SNP. Finally, a reverse MR was performed to evaluate the possibility of reverse causation.

Results

We discovered that 20 gut microbial taxa and 2 gut microbial metabolites were causally related to LBP ( p < 0.05). Among them, the lower level of family Ruminococcaceae (OR: 0.771, 95% CI: 0.652–0.913, FDR-corrected p = 0.045) and Lactobacillaceae (OR: 0.875, 95% CI: 0.801–0.955, FDR-corrected p = 0.045) retained a strong causal relationship with higher risk of LBP after the Benjamini–Hochberg Corrected test. The Cochrane’s Q test revealed no Heterogeneity ( p > 0.05). Besides, MR-Egger and MR-PRESSO tests showed no significant horizontal pleiotropy ( p > 0.05). Furthermore, leave-one-out analysis confirmed the robustness of MR results. After adding BMI to the multivariate MR analysis, the 17 gut microbial taxa exposure-outcome effect were significantly attenuated and tended to be null.

Conclusion

Our findings confirm the the potential causal effect of specific gut microbiota and gut microbial metabolites on LBP, which offers new insights into the gut microbiota-mediated mechanism of LBP and provides the theoretical basis for further explorations of targeted prevention strategies.

Schlagwörter

Stichwörter der Autor:innen

Mendeliancausalitygut microbial metabolitesgut microbiotalow back painsciatica

Autor:innen und Institutionen

  • Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Surgery, Xuanwei Hospital of Traditional Chinese Medicine, Xuanwei, China.

Zitieren

APA

Su, M., Tang, Y., Kong, W., Zhang, S., & Zhu, T. (2023). Genetically supported causality between gut microbiota, gut metabolites and low back pain: a two-sample Mendelian randomization study. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1157451

Vancouver

Su M, Tang Y, Kong W, Zhang S, Zhu T. Genetically supported causality between gut microbiota, gut metabolites and low back pain: a two-sample Mendelian randomization study. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1157451

BibTeX
@article{Su2023,
  author = {Su, Mengchan and Tang, Yidan and Kong, Weishuang and Zhang, Shuangyi and Zhu, Tao},
  title = {Genetically supported causality between gut microbiota, gut metabolites and low back pain: a two-sample Mendelian randomization study},
  journal = {Frontiers in Microbiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fmicb.2023.1157451}
}
Kostenlos starten →